نتایج جستجو برای: retinoids

تعداد نتایج: 5000  

2017
Xueju Wang Surendra Dasari Grzegorz S. Nowakowski Konstantinos N. Lazaridis Eric D. Wieben Marshall E. Kadin Andrew L. Feldman Rebecca L. Boddicker

Peripheral T-cell lymphomas (PTCLs) are aggressive non-Hodgkin lymphomas with generally poor outcomes following standard therapy. Few candidate therapeutic targets have been identified to date. Retinoic acid receptor alpha (RARA) is a transcription factor that modulates cell growth and differentiation in response to retinoids. While retinoids have been used to treat some cutaneous T-cell lympho...

Journal: :Anticancer research 2004
Laura Emionite Fabia Galmozzi Myriam Grattarola Francesco Boccardo Laura Vergani Salvatore Toma

Solid tumors develop resistance to retinoids during carcinogenesis. One of the strategies to overcome this resistance may include the combination of these molecules with other differentiating, cytotoxic or chromatin-remodelling agents. We analysed the anti-proliferative activity of two histone-deacetylase inhibitors (HDACIs), Trichostatin A (TSA) and sodium phenylbutyrate (PB), alone or combine...

2014
MASAFUMI INOKUCHI SATOKO ISHIKAWA HIROYUKI FURUKAWA HIROYUKI TAKAMURA ITASU NINOMIYA HIROHISA KITAGAWA SACHIO FUSHIDA TAKASHI FUJIMURA TETSUO OHTA

Capecitabine is a chemotherapeutic drug used in patients with breast, colon and gastric cancer. Hand-foot syndrome (HFS) is a type of dermatitis that frequently occurs as a reaction to capecitabine. To date, no effective strategies have been found to prevent or reverse HFS. Furthermore, chemotherapy induces an elevation in the expression of heparin-binding epidermal growth factor-like growth fa...

2004
Victoria Tornero Jaume Forcada Álex Aguilar

Exposure to organochlorines induces retinoid deficiency in mammals; hence, retinoids are potential biomarkers of the impact of these pollutants. Appropriate target tissues to monitor retinoids in cetaceans have not been properly identified because of a lack of information on the contribution of each tissue to total body retinoids. Therefore, we have addressed this issue by studying the contribu...

Journal: :The American Journal of Clinical Nutrition 1997

Journal: :Cancer research 1980
D L McCormick F J Burns R E Albert

tion has been achieved by beginning the retinoid supplement 7 days after a single dose of DMBA; at this time, the binding of the carcinogen to mammary panenchymalcell DNA and protein is complete, and unreacted DMBA is no longer detectable in the gland (8, 12). Comparatively little is known about possible inhibitory effects of retinoids on the early stage of mammary cancinogenesis and whether an...

Journal: : 2022

Aim. To analyze the use of retinoids in pharmaceutical practice Ukraine and world determine prospects for development domestic medicinal products containing retinoids.
 Materials methods. The study objects were local systemic medicines active substances belonging to by their composition (adapalen, tazarotene, tretinoin, acitretin, isotretinoin, etc.). For analysis recent research publicati...

Journal: :Journal of Cellular Physiology 2010

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002
Kendall Wu Hee-Tae Kim Jenny L Rodriquez Susan G Hilsenbeck Syed K Mohsin Xiao-Chun Xu William W Lamph John G Kuhn Jeff E Green Powel H Brown

Retinoids have been used in the clinic for the prevention and treatment of human cancers. They regulate several cellular processes including growth, differentiation, and apoptosis. Previously, we demonstrated that a pan-agonist retinoid 9-cis retinoic acid was able to suppress mammary tumorigenesis in the C3(1)-SV40 T-antigen (Tag) transgenic mouse model. However, significant toxicity was seen ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید